TY  - JOUR
AU  - Gutierrez-Lorenzo, Marta
AU  - Rubio-Calvo, Daniel
AU  - Urda-Romacho, Joaquin
PY  - 2021
DO  - 10.37201/req/148.2020
SN  - 0214-3429
UR  - https://hdl.handle.net/10668/24849
T2  - Revista espanola de quimioterapia
AB  - Introduction. Among the new antiretroviral treatment (ART) regimens, bictegravir (BIC) stands out, a recently incorporated integrase inhibitor. BIC conjugated with emtricitabine (FTC) and tenofovir alafenamide (TAF) has been shown to be non-inferior...
LA  - es
PB  - Sociedad espanola quimioterapia
KW  - bictegravir
KW  - HIV
KW  - economic impact
KW  - clinical practice
TI  - Effectiveness, safety, and economic impact of the bictegravir/emtricitabine/tenofovir alafenamide regimen in real clinical practice cohort of HIV-1 infected adult patients
TY  - research article
VL  - 34
ER  -